How can we create better outcomes for cancer patients?
That’s the big goal Mohit Manrao is aiming for in his work as SVP & Head of US Oncology at AstraZeneca. In this episode, Mohit shares his perspective on the future of oncology and the pursuit of patient-centric care in a post-Inflation Reduction Act world.
Join us as we discuss:
- AstraZeneca's goal of launching 15 new drugs by 2030
- Solving for disparities in care and improving health equity
- Timeline for drug development and its effect on patient outcomes
Information
- Show
- FrequencyUpdated twice weekly
- Published13 September 2023 at 08:00 UTC
- Length25 min
- RatingClean